VENTRIA BIOSCIENCE INC. – Trademark Portfolio
Entity Type: 03
VENTRIA BIOSCIENCE INC. holds 47 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 38 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. Currently, 26 trademarks are registered. Notable registered marks include EXBUMIN, LYSOBAC, OPTIFRZ, CURAVIVE, and INVITRIA. The owner is based in JUNCTION CITY, KS.
2718 INDUSTRIAL DRIVE
JUNCTION CITY, KS 66441
Showing of trademarks Trademarks
Trademark Classifications
VENTRIA BIOSCIENCE INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does VENTRIA BIOSCIENCE INC. have?
VENTRIA BIOSCIENCE INC. has 47 U.S. trademarks filed with the USPTO. Of these, 26 registered, 5 abandoned, 16 cancelled.
What trademark classes does VENTRIA BIOSCIENCE INC. file in?
VENTRIA BIOSCIENCE INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are VENTRIA BIOSCIENCE INC.'s most well-known trademarks?
VENTRIA BIOSCIENCE INC.'s registered trademark portfolio includes well-known marks such as EXBUMIN, LYSOBAC, OPTIFRZ, CURAVIVE, and INVITRIA. These are among 26 currently registered trademarks in the portfolio.
What is VENTRIA BIOSCIENCE INC.'s trademark registration success rate?
VENTRIA BIOSCIENCE INC. has a 55% trademark registration rate, with 26 out of 47 resolved applications resulting in successful registration. Currently, 0 applications are pending review.